1,029 results on '"Lindeman, Neal"'
Search Results
152. Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
153. Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study
154. Updated biomarker results from a phase 1/2 study of olaparib and radium-223 in men with metastatic castration-resistant prostate cancer (mCRPC) with bone metastases (COMRADE).
155. MatchMiner: An open source platform for cancer precision medicine
156. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
157. Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study
158. Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva
159. Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
160. Precision of Pyrosequencing Assay to Measure LINE-1 Methylation in Colon Cancer, Normal Colonic Mucosa, and Peripheral Blood Cells
161. An optimized protocol for evaluating pathogenicity of VHL germline variants in patients suspected with von Hippel-Lindau syndrome: Using somatic genome to inform the role of germline variants
162. Assessment of genomic alterations in non-syndromic von Hippel-Lindau: Insight from integrating somatic and germline next generation sequencing genomic data
163. Brave-ish New World—What’s Needed to Make Precision Oncology a Practical Reality
164. Impact of a Prospective Review Program for Reference Laboratory Testing Requests
165. Chapter 31 - Application of Modern Techniques
166. Ultrasensitive Detection of SALL4 Oncoproteins in Peripheral Blood and Bone Marrow Aspirate: Companion Diagnostics and Therapeutic Monitoring
167. Intravascular cytotoxic T-cell lymphoma: A case report and review of the literature
168. Targeted genomic analysis of Müllerian adenosarcoma‡
169. Keynote Lecture: KN01 EGFR AND BEYOND: EVOLUTION OF MOLECULAR CLASSIFICATION OF LUNG CANCER
170. Identification of a melanoma susceptibility locus and somatic mutation in TET2
171. EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer
172. How SARS-CoV-2 Transformed the Clinical Laboratory: Challenges and Lessons Learned
173. Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients
174. Twists and turns from “tumor in tumor” profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis
175. Identification and management of pathogenic mutations in BRCA1, BRCA2, and PALB2 in a tumor-only genomic testing program.
176. 122 MUTATIONAL LANDSCAPE OF INFLAMMATORY BOWEL DISEASE-ASSOCIATED COLORECTAL CANCER COMPARED TO A MATCHED COHORT OF SPORADIC COLORECTAL CANCER
177. LKB1 modulates lung cancer differentiation and metastasis
178. Twists and turns from 'tumor in tumor' profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis.
179. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices
180. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer
181. Reporting Results of Molecular Tests: A Retrospective Examination of BRAF Mutation Reporting
182. Epidermal Growth Factor Receptor Testing in Lung Adenocarcinoma
183. Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy
184. Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
185. Germline testing data validate inferences of mutational status for variants detected from tumor-only sequencing
186. Fatty acid synthesis is required for breast cancer brain metastasis
187. A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study
188. Genomic Characterization of de novo Metastatic Breast Cancer
189. Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium
190. Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants
191. Molecular Pathology of Soft Tissue and Bone Tumors
192. Molecular Pathology of Lung Cancers
193. One patient, two lymphomas: simultaneous primary gastric marginal zone lymphomaand primary duodenal follicular lymphoma
194. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy
195. Treatment-Related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung
196. Refrigeration is not necessary for measurement of uric acid in patients treated with rasburicase
197. Sarcomatoid Yolk Sac Tumor Harbors Somatic Mutations That Are Otherwise Rare in Testicular Germ Cell Tumors.
198. Practical Considerations Relating to Routine Clinical Biomarker Testing for Non–small Cell Lung Cancer: Focus on Testing for RET Fusions
199. An Overview of Characteristics of Clinical Next-Generation Sequencing–Based Testing for Hematologic Malignancies
200. Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.